Accuray Incorporated (LON:0H8I)

Market Cap	25.51M -78.1%
Revenue (ttm)	324.56M -7.9%
Net Income	-34.93M
EPS	-0.30
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,795
Open	0.2808
Previous Close	0.3018
Day's Range	0.2790 - 0.3030
52-Week Range	0.2280 - 2.2000
Beta	1.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1990
• Employees: 990
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H8I

Financial Performance

In fiscal year 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 12, 2026

Data Sources Report a data error